Cost considerations regarding an integrated CT-PET system

被引：39

作者：

von Schulthess, GK ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Med Radiol, Nucl Med & MR Ctr, CH-8091 Zurich, Switzerland

来源：

EUROPEAN RADIOLOGY | 2000年 / 10卷 / Suppl 3期

关键词：

D O I：

10.1007/PL00014098

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：S377 / S380

页数：4

共 6 条

[1]

Gupta NC, 1996, J NUCL MED, V37, P943

[2] MALIGNANT-MELANOMA - STAGING WITH WHOLE-BODY POSITRON EMISSION TOMOGRAPHY AND 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE [J].

STEINERT, HC ;

BONI, RAH ;

BUCK, A ;

BONI, R ;

BERTHOLD, T ;

MARINCEK, B ;

BURG, G ;

VONSCHULTHESS, GK .

RADIOLOGY, 1995, 195 (03) :705-709

[3] Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling [J].

Steinert, HC ;

Hauser, M ;

Allemann, F ;

Engel, H ;

Berthold, T ;

vonSchulthess, GK ;

Weder, W .

RADIOLOGY, 1997, 202 (02) :441-446

[4] Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography [J].

Stumpe, KDM ;

Urbinelli, M ;

Steinert, HC ;

Glanzmann, C ;

Buck, A ;

von Schulthess, GK .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (07) :721-728

[5]

TOWNSEND W, 1998, M501 IEEE MIC

[6]

VONSCHULTHESS GK, 2000, CLIN POSITRON EMISSI

← 1 →